| pubmed-article:11416978 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11416978 | lifeskim:mentions | umls-concept:C0008059 | lld:lifeskim |
| pubmed-article:11416978 | lifeskim:mentions | umls-concept:C0013080 | lld:lifeskim |
| pubmed-article:11416978 | lifeskim:mentions | umls-concept:C0086045 | lld:lifeskim |
| pubmed-article:11416978 | lifeskim:mentions | umls-concept:C0019932 | lld:lifeskim |
| pubmed-article:11416978 | lifeskim:mentions | umls-concept:C0312452 | lld:lifeskim |
| pubmed-article:11416978 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:11416978 | pubmed:dateCreated | 2001-6-21 | lld:pubmed |
| pubmed-article:11416978 | pubmed:abstractText | The incidence of hypothyroidism is higher among children with Down syndrome than among children in the general population. The frequency of hypothyroidism is higher in the areas of endemic goiter than in other areas. The aim of this paper was to study the concentrations of TSH and FT4 in children with Down syndrome residents of Mérida, a region of Venezuelan Andes. At the Centro de Estudio y Prevención del Retardo Mental y Alteraciones en el Desarrollo (CEPREMAD), the thyroid function was studied in 48 children (1 month to 6 years old), who had Down syndrome, and in 123 healthy children of similar ages. All the children were referred to the Center for thyroid function evaluation. Two (4.2%) of the 48 children with Down syndrome had congenital hypothyroidism and 22 (45.8%) had subclinical hypothyroidism (high concentration of thyrotropin-TSH). Among the control children, only 14% had elevated levels of TSH. There were no differences in relation to the gender. In conclusion in children with Down syndrome, the frequency of high concentrations of TSH was three times higher than the frequency among the healthy children. The frequency of hypothyroidism was similar to that found in areas without endemic goiter. | lld:pubmed |
| pubmed-article:11416978 | pubmed:language | spa | lld:pubmed |
| pubmed-article:11416978 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11416978 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11416978 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11416978 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11416978 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11416978 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11416978 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:11416978 | pubmed:issn | 0535-5133 | lld:pubmed |
| pubmed-article:11416978 | pubmed:author | pubmed-author:AriasAA | lld:pubmed |
| pubmed-article:11416978 | pubmed:author | pubmed-author:PaoliMM | lld:pubmed |
| pubmed-article:11416978 | pubmed:author | pubmed-author:DelgadoM CMC | lld:pubmed |
| pubmed-article:11416978 | pubmed:author | pubmed-author:VivasEE | lld:pubmed |
| pubmed-article:11416978 | pubmed:author | pubmed-author:Jiménez-López... | lld:pubmed |
| pubmed-article:11416978 | pubmed:author | pubmed-author:Arata-Bellaba... | lld:pubmed |
| pubmed-article:11416978 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11416978 | pubmed:volume | 42 | lld:pubmed |
| pubmed-article:11416978 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11416978 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11416978 | pubmed:pagination | 123-30 | lld:pubmed |
| pubmed-article:11416978 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:11416978 | pubmed:meshHeading | pubmed-meshheading:11416978... | lld:pubmed |
| pubmed-article:11416978 | pubmed:meshHeading | pubmed-meshheading:11416978... | lld:pubmed |
| pubmed-article:11416978 | pubmed:meshHeading | pubmed-meshheading:11416978... | lld:pubmed |
| pubmed-article:11416978 | pubmed:meshHeading | pubmed-meshheading:11416978... | lld:pubmed |
| pubmed-article:11416978 | pubmed:meshHeading | pubmed-meshheading:11416978... | lld:pubmed |
| pubmed-article:11416978 | pubmed:meshHeading | pubmed-meshheading:11416978... | lld:pubmed |
| pubmed-article:11416978 | pubmed:meshHeading | pubmed-meshheading:11416978... | lld:pubmed |
| pubmed-article:11416978 | pubmed:meshHeading | pubmed-meshheading:11416978... | lld:pubmed |
| pubmed-article:11416978 | pubmed:meshHeading | pubmed-meshheading:11416978... | lld:pubmed |
| pubmed-article:11416978 | pubmed:meshHeading | pubmed-meshheading:11416978... | lld:pubmed |
| pubmed-article:11416978 | pubmed:meshHeading | pubmed-meshheading:11416978... | lld:pubmed |
| pubmed-article:11416978 | pubmed:meshHeading | pubmed-meshheading:11416978... | lld:pubmed |
| pubmed-article:11416978 | pubmed:year | 2001 | lld:pubmed |
| pubmed-article:11416978 | pubmed:articleTitle | [Concentration of thyrotropic hormone and free thyroxin in children with Down's syndrome]. | lld:pubmed |
| pubmed-article:11416978 | pubmed:affiliation | Centro de Desarrollo Infantil Mérida, Centro de Estudio y Prevención del Retardo Mental y Alteraciones en el Desarrollo (CEPREMAD), Universidad de Los Andes, Mérida, Venezuela. | lld:pubmed |
| pubmed-article:11416978 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11416978 | pubmed:publicationType | English Abstract | lld:pubmed |
| pubmed-article:11416978 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
